Cerner Co. (CERN) Given Average Recommendation of “Buy” by Brokerages

Shares of Cerner Co. (NASDAQ:CERN) have been given an average rating of “Buy” by the seventeen research firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and ten have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $68.67.

Several equities analysts have commented on the stock. Zacks Investment Research upgraded shares of Cerner from a “sell” rating to a “hold” rating in a research note on Tuesday, March 26th. Cantor Fitzgerald reiterated a “buy” rating and issued a $75.00 price target on shares of Cerner in a research note on Tuesday, April 9th. Robert W. Baird increased their price target on shares of Cerner from $67.00 to $71.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Citigroup set a $77.00 price target on shares of Cerner and gave the company a “buy” rating in a research note on Wednesday, April 10th. Finally, SunTrust Banks upgraded shares of Cerner from a “hold” rating to a “buy” rating and increased their price target for the company from $60.00 to $76.00 in a research note on Wednesday, April 10th.

CERN stock opened at $62.40 on Thursday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.38 and a current ratio of 2.41. Cerner has a fifty-two week low of $48.78 and a fifty-two week high of $67.57. The company has a market cap of $20.39 billion, a P/E ratio of 28.24, a PEG ratio of 1.98 and a beta of 0.97.

Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Tuesday, February 5th. The company reported $0.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.57 by $0.06. The company had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.39 billion. Cerner had a net margin of 11.74% and a return on equity of 14.84%. The firm’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.58 earnings per share. Analysts anticipate that Cerner will post 2.39 EPS for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the company. Brown Advisory Inc. grew its position in shares of Cerner by 6.6% during the fourth quarter. Brown Advisory Inc. now owns 11,983 shares of the company’s stock worth $629,000 after acquiring an additional 740 shares during the last quarter. Parnassus Investments CA grew its position in shares of Cerner by 36.5% during the fourth quarter. Parnassus Investments CA now owns 9,829,823 shares of the company’s stock worth $515,476,000 after acquiring an additional 2,626,045 shares during the last quarter. Reinhart Partners Inc. grew its position in shares of Cerner by 3.0% during the first quarter. Reinhart Partners Inc. now owns 304,317 shares of the company’s stock worth $17,410,000 after acquiring an additional 8,932 shares during the last quarter. Legal & General Group Plc grew its position in shares of Cerner by 6.5% during the fourth quarter. Legal & General Group Plc now owns 1,635,943 shares of the company’s stock worth $85,772,000 after acquiring an additional 99,225 shares during the last quarter. Finally, First Command Bank purchased a new position in shares of Cerner during the fourth quarter worth approximately $122,000. Institutional investors and hedge funds own 80.81% of the company’s stock.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Further Reading: Growth Stocks, What They Are, What They Are Not

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.